Influ2
Account-based marketing platform that targets and tracks individual decision-makers with ads and messaging, instead of treating a whole company as one target.
🔗 Visit Influ2
Description
Most 'account-based marketing' tools treat a target company as one single blob — you decide a big company is a good prospect, then blast generic ads and emails at that company as a whole. Influ2 does something more precise: it lets a marketing team target the actual individual people inside that company who make the buying decision, show each of them personalized ads, and track exactly how each specific person is engaging — not just how the company as a whole is behaving. It's the difference between mailing a flyer to a street address versus addressing it to the specific person who actually opens the mail and decides whether to call you back.
Technically, Influ2 runs contact-level intent signals and ad targeting (ads that follow specific named individuals, not just a company's IP range), a 'cohort builder' to group and segment buying-committee members, buyer-journey orchestration, revenue attribution tied back to individual contacts, and a real-time 'Signals Center' plus CRM integrations to feed all of that back into the sales pipeline. Influ2's own published metric is that buying groups with at least one ad click show 2.18x higher pipeline conversion — a data point specific enough to suggest it's tracking real attribution, not just impressions. It's aimed at mid-market to enterprise B2B marketing and sales teams running structured ABM programs, not small self-serve teams: pricing is fully custom and undisclosed, requiring a demo and sales conversation before you see a number.
💬 Our review
The short version: Influ2's contact-level approach to ABM is a genuinely different idea from account-level ABM tools, and its 2.18x pipeline-conversion stat for engaged buying groups is specific enough to take seriously — but you'll need to book a demo just to find out if it fits your budget at all.
None of the other tools in this category do quite what Influ2 does — Apollo.io and Amplemarket target and enrich individual contacts too, but for direct outreach (email, calls) rather than ad-based ABM targeting, and Influ2 is closer to a marketing-department tool than a sales-rep tool. That's a real strength if your buying committee has 5-10 stakeholders and account-level ads are wasting budget on the wrong people inside the right company. The weakness is the same one that shows up across enterprise ABM tools generally: zero public pricing, custom quotes only, which makes it hard to know upfront whether you're looking at a modest annual commitment or a large one, and there's no disclosed customer count or case study roster to sanity-check its claims against. If your team is smaller and needs direct multichannel outreach rather than ad-based account marketing, something like Reply.io or Apollo.io is a more natural, and more transparently priced, starting point.
💰 Pricing
📊 Global score
🤖 AI-enriched data
Custom pricing only; requires a demo request and sales consultation. No published tiers or starting price.
Pros
Targets and tracks individual decision-makers, not just whole accounts — a genuinely different approach from typical ABM tools
Published, specific metric (2.18x higher pipeline conversion for engaged buying groups) rather than vague marketing claims
Revenue attribution tied to individual contacts, not aggregated account-level guesses
Real-time Signals Center plus CRM integrations connect marketing activity directly to the sales pipeline
Cons
Fully custom, undisclosed pricing — no number available without a sales call
No public customer count, case studies, or funding figures to verify claims
Built for mid-market/enterprise ABM programs, overkill for small or early-stage teams
Ad-based contact targeting model requires a real buying-committee-style sale, not a quick one-person deal